Catalyst Wire Dossier Catalyst Wire Dossier
CLINICAL_TRIALS research · 2013-09-04

Clinical Trial Update: An Observational Study to Investigate Clinical Usefulness of OROS Hydromorphone in Korean Cancer Patients

View source ↗

Summary

An observational study conducted in Korea evaluated the clinical usefulness of the OROS Hydromorphone formulation for cancer-related pain; the trial status is c…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

Drugs mentioned

  • OROS Hydromorphone (hydromorphone)

Snippet

Sponsor: Janssen Korea, Ltd., Korea | Conditions: Pain | Status: COMPLETED